Akorn revenues rise in Q3
Akorn has posted a net income of $3.99m for the third quarter 2010, or $0.04 per diluted share, compared to net loss of $5.1m, or $0.06 loss per
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems, provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. As per the